Serotonin transporter protein in autopsied brain of chronic users of cocaine.
Cocaine
Heroin
Postmortem human brain
Serotonin transporter
Western blot
Journal
Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
03
02
2020
accepted:
18
05
2020
pubmed:
5
6
2020
medline:
29
12
2020
entrez:
5
6
2020
Statut:
ppublish
Résumé
The long-held speculation that the brain serotonin system mediates some behavioral effects of the psychostimulant cocaine is supported in part by the high affinity of cocaine for the serotonin transporter (SERT) and by reports that the serotonin transporter (SERT), estimated by SERT binding, is increased in brain of human chronic cocaine users. Excessive SERT activity and consequent synaptic serotonin deficiency might cause a behavioral (e.g., mood) abnormality in chronic users of the drug. Previous studies focused on changes in SERT binding, which might not necessarily reflect changes in SERT protein. Therefore, we compared levels of SERT protein, using a quantitative Western blot procedure, in autopsied brain (striatum, cerebral cortices) of chronic human cocaine users (n = 9), who all tested positive for the drug/metabolite in brain, to those in control subjects (n = 15) and, as a separate drug of abuse group, in chronic heroin users (n = 11). We found no significant difference in protein levels of SERT or the serotonin synthesizing enzyme tryptophan hydroxylase-2 among the control and drug abuse groups. In the cocaine users, no significant correlations were observed between SERT and brain levels of cocaine plus metabolites, or with levels of serotonin or its metabolite 5-hydroxyindoleacetic acid. Our postmortem data suggest that a robust increase in striatal/cerebral cortical SERT protein is not a common characteristic of chronic, human cocaine users.
Identifiants
pubmed: 32494974
doi: 10.1007/s00213-020-05562-4
pii: 10.1007/s00213-020-05562-4
pmc: PMC7502513
mid: NIHMS1600872
doi:
Substances chimiques
Dopamine Uptake Inhibitors
0
SLC6A4 protein, human
0
Serotonin Plasma Membrane Transport Proteins
0
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2661-2671Subventions
Organisme : NIDA NIH HHS
ID : R01 DA007182
Pays : United States
Organisme : NIDA NIH HHS
ID : DA07182
Pays : United States
Références
J Neurol Neurosurg Psychiatry. 1959 Aug;22:247-51
pubmed: 14430381
J Pharmacol Exp Ther. 1996 Mar;276(3):1292-303
pubmed: 8786562
J Neurosci. 2002 Aug 1;22(15):6766-72
pubmed: 12151556
J Neurosci. 1994 May;14(5 Pt 2):2966-79
pubmed: 8182452
J Psychopharmacol. 2010 Feb;24(2):281-4
pubmed: 18832433
Science. 1991 Oct 25;254(5031):579-80
pubmed: 1948036
J Pharmacol Exp Ther. 1993 Jan;264(1):183-92
pubmed: 8093724
J Neurosci Methods. 2002 Mar 15;114(2):205-12
pubmed: 11856572
Brain Res Bull. 2011 Apr 5;84(6):376-80
pubmed: 21272616
Adv Pharmacol. 2014;69:129-76
pubmed: 24484977
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2416-25
pubmed: 22826342
Nature. 2019 May;569(7754):141-145
pubmed: 31019304
Br J Pharmacol. 2017 Aug;174(16):2716-2738
pubmed: 28585320
Am J Psychiatry. 2000 Jul;157(7):1134-40
pubmed: 10873923
Neuropharmacology. 2014 Jan;76 Pt B:460-78
pubmed: 23850573
Neuropharmacology. 2018 Nov;142:63-71
pubmed: 29246856
Neuroimage. 2010 Aug 1;52(1):50-4
pubmed: 20406689
J Chem Neuroanat. 2000 Dec;20(3-4):271-80
pubmed: 11207425
J Neurosci. 1999 Dec 1;19(23):10494-501
pubmed: 10575045
Eur J Pharmacol. 1969 Sep;7(3):270-7
pubmed: 5351984
J Neural Transm (Vienna). 2001;108(6):707-16
pubmed: 11478422
Arch Gen Psychiatry. 2000 Aug;57(8):729-38
pubmed: 10920459
Ann Neurol. 1996 Sep;40(3):428-39
pubmed: 8797532
Brain Plast. 2016 Jun 29;1(2):177-206
pubmed: 29765841
Pharmacol Ther. 2020 Jan;205:107417
pubmed: 31629010
Psychopharmacology (Berl). 2009 Mar;202(4):649-61
pubmed: 18841348
Psychiatry Res. 2010 Dec 30;184(3):192-5
pubmed: 21050726
Am J Psychiatry. 1998 Feb;155(2):207-13
pubmed: 9464199
N Engl J Med. 1988 Apr 7;318(14):876-80
pubmed: 3352672
Nucl Med Biol. 2005 Feb;32(2):123-8
pubmed: 15721757
J Cereb Blood Flow Metab. 2013 Jun;33(6):863-71
pubmed: 23403377
Biochem Pharmacol. 2012 Feb 15;83(4):435-42
pubmed: 21983034
Arch Gen Psychiatry. 1976 Jul;33(7):811-9
pubmed: 133650
Biochem J. 2015 May 15;468(1):177-90
pubmed: 25761794
J Psychiatry Neurosci. 2007 Mar;32(2):86-102
pubmed: 17353938
Brain. 2010 Jun;133(Pt 6):1779-97
pubmed: 20483717
Neuropsychopharmacology. 2008 Jan;33(2):219-25
pubmed: 17443127
Biol Psychiatry. 2000 Apr 1;47(7):643-9
pubmed: 10745057
Synapse. 1992 Jun;11(2):112-23
pubmed: 1385662
Trends Pharmacol Sci. 2013 Oct;34(10):560-70
pubmed: 24041919
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2542-6
pubmed: 7681602
Neuropsychopharmacology. 2017 Apr;42(5):1082-1092
pubmed: 27857126
Neuropharmacology. 2014 Dec;87:19-40
pubmed: 24953830
Pharmacol Biochem Behav. 2019 May;180:52-59
pubmed: 30811963
Br J Psychiatry. 2011 Nov;199(5):391-7
pubmed: 21543823
J Biol Chem. 1998 Jan 23;273(4):2458-66
pubmed: 9442097
Nat Commun. 2017 Jan 19;8:14089
pubmed: 28102201
Eur J Pharmacol. 2010 Mar 10;629(1-3):63-7
pubmed: 20006597
Exp Clin Psychopharmacol. 2018 Oct;26(5):488-496
pubmed: 29952618
Alcohol Clin Exp Res. 2007 Jan;31(1):28-32
pubmed: 17207098
Neuroscience. 2017 Sep 17;359:30-39
pubmed: 28711621
Brain. 2008 Jan;131(Pt 1):120-31
pubmed: 17956909
Synapse. 1998 Apr;28(4):322-38
pubmed: 9517841
Neuropharmacology. 2011 Jul-Aug;61(1-2):245-51
pubmed: 21521647
Brain Res. 1996 Oct 14;736(1-2):287-96
pubmed: 8930335
J Forensic Sci. 2000 Sep;45(5):1041-8
pubmed: 11005179
J Neurochem. 1994 Feb;62(2):549-56
pubmed: 8294917
J Biol Chem. 2002 Apr 26;277(17):14475-82
pubmed: 11844791
Psychopharmacology (Berl). 1989;99(2):147-50
pubmed: 2508148
Psychopharmacology (Berl). 1981;73(2):110-5
pubmed: 6785800
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7699-704
pubmed: 9636213
Neuropsychopharmacology. 2012 Jul;37(8):1816-24
pubmed: 22434223
J Nucl Med. 2012 Jul;53(7):1065-73
pubmed: 22689927
Neuropsychopharmacology. 2001 May;24(5):561-7
pubmed: 11282256
Drug Alcohol Depend. 2018 Sep 1;190:20-28
pubmed: 29960919